At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Open-Label, Single-Arm, Baseline-Controlled, Multicenter Study to Explore the Safety, Tolerability, Pharmacokinetics, and Efficacy of ABT-SLV187 in Subjects With Advanced Parkinson's Disease
In Brief
A Phase 2 clinical trial evaluating ABT-SLV187, Oral Levodopa/Carbidopa, and 3 other interventions for Advanced Parkinson's Disease. Completed, enrolled 8 participants.
Detailed Summary
To explore the safety, tolerability, pharmacokinetics and efficacy of ABT-SLV187 in advanced Parkinson's disease (PD) patients with severe motor complications. The complications of medical devices for the naso-jejunum (NJ) infusion system of ABT-SLV187 will also be investigated.
Study Details
Timeline
Interventions
Tablet; contains 100 mg levodopa and 10 mg carbidopa
General infusion pump, manufactured by Smiths Medical (US)
Device used to deliver nutrition/drug to stomach/intestine or to aspirate stomach fluid, manufactured by Create Medic Co., Ltd. (Japan)
Accessory set for fluid infusion set, consisting of caps, connectors and adapters, etc, manufactured by Hakko Medical (Japan)